Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign

Cancer

Volumn 112, Issue 1, 2008, Pages 212-219

  Umutyan, Ari ^a   Chiechi, Christine ^a   Beckett, Laurel A ^a   Paterniti, Debora A ^a,b   Turrell, Corinne ^a   Gandara, David R ^a,d   Davis, Sharon W ^c   Wun, Ted ^a,d   Chen Jr , Moon S ^a   Lara Jr , Primo N ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Health Services Research in Primary Care   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Accrual rate; Barriers to participation; California Law SB37; Cancer clinical trials

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; AWARENESS; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; NEGRO; NEOPLASM; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INSURANCE COVERAGE; MALE; MASS MEDIA; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; REFUSAL TO PARTICIPATE;

EID: 37449024449     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23170     Document Type: Article

References (28)

1. Joseph R. Viewpoints and concerns of a clinical trial participant. Cancer. 1994;74:2692-2693.
2. Saetern WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
3. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer. 1994;74(7 suppl):2208-2214.
4. Kaluzny A, Brawley O, Garson-Angert D, et al. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst. 1993;85: 1945-1950.
5. Tejada HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute treatment trials. J Natl Cancer Inst. 1996;88: 812-816.
6. National Children's Cancer Foundation Web site: Childhood cancer facts. Available at URL: http://www.nccf.org/ Accessed July 2007.
7. Kolata G, Eichewald K. In pediatrics, a lesson in making use of experimental procedures. New York Times, October 3, 1999, section 1, p 40.
8. Ehrlich PF, Newman KD, Haase GM, et al. Lessons learned from a failed multi-institutional randomized controlled study. J Pediatr Surg. 2002;37:431-436.
9. Haidich AB, Ioannidis JP. Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol. 2001;154:873-880.
10. Stiller C. Centralised treatment, entry to trials, and survival. Br J Cancer. 1994;70:352-362.
11. Martel CL, Li Y, Beckett L, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004;10:294-300.
12. Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999;17:1601-1617.
13. Lara PN, Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19:1728-1733.
14. Lara PN, Jr, Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005;23:9282-9289.
15. SAS Institute, Inc. SAS/STAT Version 9.0. Cary, NC: SAS Institute, Inc.; 2004.
16. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2006.
17. Enders SR, Horan NM, Lara PN, Paterniti DA. Patient and family perceptions of recruitment to cancer clinical trials (CCTs). ASCO Meeting Abstracts. 2005;23(suppl):16S. Abstract 6115.
18. Ellis PM, Butow PN, Tattersall MH, et al. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19:3554-3561.
19. Comis RL, Miller JD, Aldige CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21:830-835.
20. Grunfeld E, Zitzelsberger L, Coristine M, et al. Barriers and facilitators to enrollment in cancer clinical trials. Cancer. 2002;95:1577-1583.
21. Simon MS, Wei D, Flaherty L, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol. 2004;22: 2046-2052.
22. Siminoff LA, Zhang A, Colabianchi N, et al. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol. 2000;18:1203-1211.
23. Kemeny MM, Peterson BL, Kornblith AB, et al. Barriers to cancer trial participation by older women with breast cancer. J Clin Oncol. 2003;21:2268-2275.
24. Townsley CA, Naidoo K, Pond GR, et al. Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns. J Clin Oncol. 2003;21:4627-4635.
25. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med. 1984;310: 1363-137.
26. Benson AB 3rd, Pregler JP, Bean JA, et al. Oncologists' reluctance to accrue patients onto clinical trials: Illinois Cancer Center Study. J Clin Oncol. 1991;9:2067-2075.
27. Fallowfield L, Ratcliffe D, Souhami R. Clinician's attitudes to clinical trials of cancer therapy. Eur J Cancer. 1997;33: 2221-229.
28. Madsen SM, Mirza MR, Holm S, et al. Attitudes towards clinical research amongst participants and nonparticipants. J Intern Med. 2002;251:156-168.